← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4, two pages.
InvestVerdict

Mahindra Manulife Flexi Cap Fund

Direct Plan · Growth · Flexi Cap · Scheme code 149104

Fund houseMahindra Manulife Mutual Fund
CategoryFlexi Cap
Plan & optionDirect · Growth
History5.0 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 1.905.711.43 3.3611.9512.06 12.05
Nifty 500
benchmark
0.874.312.15 5.2012.4911.41 15.49
Flexi Cap
category median
4.2913.9512.40 13.88

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fall
This scheme 13.7% 0.40 0.55 0.94 1.38% -17.2% 96.18
Nifty 500
benchmark
17.2%0.35 0.47 -37.3%

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 60 months this scheme and its benchmark share.

Growth of ₹100 since launch

82118153189202220242026InvestVerdict

Drawdown from peak (%)

0%-6%-13%-19%202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
197 -4.0% 9.8% 42.7% 11%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

InvestVerdict

Mahindra Manulife Flexi Cap Fund

Direct Plan · Growth

Allocation

By asset

Equity95.67%
Cash & Equivalents5.71%
Debt0.02%

By market cap

Concentration

Number of stocks72
Top 5 stocks21.96%
Top 10 stocks32.03%
Top 20 stocks47.48%
Largest holding8.42%
Largest sectorBanks 22.39%
Effective stocks47.4
Cash5.71%
InvestVerdict

Mahindra Manulife Flexi Cap Fund

Direct Plan · Growth · holdings

Sector split

Banks — 22.4%Retailing — 7.4%Pharmaceuticals & Biotechnology — 6.9%Finance — 6.1%Cash & Equivalents — 5.7%IT - Software — 4.7%Automobiles — 4.5%Industrial Products — 4.3%Telecom - Services — 4.2%Other — 35.2%Banks22.4%Retailing7.4%Pharmaceuticals & Biotech…6.9%Finance6.1%Cash & Equivalents5.7%IT - Software4.7%Automobiles4.5%Industrial Products4.3%Telecom - Services4.2%Other35.2%
Banks22.39%
Retailing7.37%
Pharmaceuticals & Biotechnology6.89%
Finance6.13%
Cash & Equivalents5.71%
IT - Software4.69%
Automobiles4.52%
Industrial Products4.29%
Telecom - Services4.24%
Consumer Durables4.00%

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹806,256 ₹206,256 11.78%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. InvestVerdict is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 30 Aug 2026.